Relationship of plasma cytokines and clinical biomarkers to memory performance in HIV

Journal of Neuroimmunology

Volumn 265, Issue 1-2, 2013, Pages 117-123

  Correia, Stephen ^a   Cohen, Ronald ^a,b,d,e   Gongvatana, Assawin ^a,b   Ross, Skye ^b   Olchowski, James ^b   Devlin, Kathryn ^b   Tashima, Karen ^a   Navia, Bradford ^c   Delamonte, Suzanne ^a  

^a BROWN UNIVERSITY   (United States)

^b MIRIAM HOSPITAL   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF FLORIDA   (United States)

^e UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

CART; Cytokines; Hepatitis C; HIV; HIV clinical markers; Memory

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 16; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; STROMAL CELL DERIVED FACTOR 1ALPHA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ADULT; AGED; ARTICLE; BRAIN FUNCTION; CHRONIC DISEASE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; INFLAMMATION; LEARNING DISORDER; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MENTAL PERFORMANCE; PATIENT MONITORING; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN MICROARRAY; SERODIAGNOSIS; THERAPY EFFECT; VERBAL MEMORY;

CART; CYTOKINES; HEPATITIS C; HIV; HIV CLINICAL MARKERS; MEMORY;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTIGENS, CD4; BIOLOGICAL MARKERS; CHEMOKINE CCL2; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEMORY DISORDERS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; VERBAL LEARNING; YOUNG ADULT;

EID: 84888366090     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2013.09.005     Document Type: Article

References (67)

1. Akaike H. A new look at the statistical model identification. IEEE Trans. Autom. Control 1974, 19:716-723.
2. Albright A.V., Gonzalez-Scarano F. Microarray analysis of activated mixed glial (microglia) and monocyte-derived macrophage gene expression. J. Neuroimmunol. 2004, 157:27-38.
3. Alcendor D.J., Charest A.M., Zhu W.Q., Vigil H.E., Knobel S.M. Infection and upregulation of proinflammatory cytokines in human brain vascular pericytes by human cytomegalovirus. J. Neuroinflammation 2012, 9:95.
4. Barber S.A., Uhrlaub J.L., Dewitt J.B., Tarwater P.M., Zink M.C. Dysregulation of mitogen-activated protein kinase signaling pathways in simian immunodeficiency virus encephalitis. Am. J. Pathol. 2004, 164:355-362.
5. Benedict R., Schretlen D., Groninger L., Brandt J. Hopkins verbal learning test - revised: normative data and analysis of inter-form and test retest-reliability. Clin. Neuropsychol. 1998, 12:43-55.
6. Burnham K.P., Anderson D.R. Model selection and multimodel inference: a practical-theoretic approach 2002, Springer-Verlag, New York. 2nd edition.
7. Cartier L., Hartley O., Dubois-Dauphin M., Krause K.H. Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases. Brain Res. Brain Res. Rev. 2005, 48:16-42.
8. Chang L., Lee P.L., Yiannoutsos C.T., Ernst T., Marra C.M., Richards T., Kolson D., Schifitto G., Jarvik J.G., Miller E.N., Lenkinski R., Gonzalez G., Navia B.A. A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age. Neuroimage 2004, 23:1336-1347.
9. Chiodi F. A link between immune hyperactivation of T cells during HIV-1 infection and the virus protease?. AIDS 2006, 20:769-771.
10. Cohen R.A., Boland R., Paul R., Tashima K.T., Schoenbaum E.E., Celentano D.D., Schuman P., Smith D.K., Carpenter C.C. Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women. AIDS 2001, 15:341-345.
11. Cohen R.A., Harezlak J., Gongvatana A., Buchthal S., Schifitto G., Clark U., Paul R., Taylor M., Thompson P., Tate D., Alger J., Brown M., Zhong J., Campbell T., Singer E., Daar E., Mcmahon D., Tso Y., Yiannoutsos C.T., Navia B. Cerebral metabolite abnormalities in human immunodeficiency virus are associated with cortical and subcortical volumes. J. Neurovirol. 2010, 16:435-444.
12. Cohen R.A., De La Monte S., Gongvatana A., Ombao H., Gonzalez B., Devlin K.N., Navia B., Tashima K.T. Plasma cytokine concentrations associated with HIV/hepatitis C coinfection are related to attention, executive and psychomotor functioning. J. Neuroimmunol. 2011, 233:204-210.
13. Cysique L.A., Brew B.J. Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of plasma HIV RNA suppression. J. Neurovirol. 2011, 17:176-183.
14. Dickerson B.C., Eichenbaum H. The episodic memory system: neurocircuitry and disorders. Neuropsychopharmacology 2010, 35:86-104.
15. Feuerstein G.Z., Liu T., Barone F.C. Cytokines, inflammation, and brain injury: role of tumor necrosis factor-alpha. Cerebrovasc. Brain Metab. Rev. 1994, 6:341-360.
16. Garvey L., Surendrakumar V., Winston A. Low rates of neurocognitive impairment are observed in neuro-asymptomatic HIV-infected subjects on effective antiretroviral therapy. HIV Clin. Trials 2011, 12:333-338.
17. Gisolf E.H., Van Praag R.M., Jurriaans S., Portegies P., Goudsmit J., Danner S.A., Lange J.M., Prins J.M. Increasing cerebrospinal fluid chemokine concentrations despite undetectable cerebrospinal fluid HIV RNA in HIV-1-infected patients receiving antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 2000, 25:426-433.
18. Gonzalez-Scarano F., Martin-Garcia J. The neuropathogenesis of AIDS. Nat. Rev. Immunol. 2005, 5:69-81.
19. Gorg B., Bidmon H.J., Keitel V., Foster N., Goerlich R., Schliess F., Haussinger D. Inflammatory cytokines induce protein tyrosine nitration in rat astrocytes. Arch. Biochem. Biophys. 2006, 449:104-114.
20. Grant I. Neurocognitive disturbances in HIV. Int. Rev. Psychiatry 2008, 20:33-47.
21. Gray F., Scaravilli F., Everall I., Chretien F., An S., Boche D., Adle-Biassette H., Wingertsmann L., Durigon M., Hurtrel B., Chiodi F., Bell J., Lantos P. Neuropathology of early HIV-1 infection. Brain Pathol. 1996, 6:1-15.
22. Guyon A., Massa F., Rovere C., Nahon J.L. How cytokines can influence the brain: a role for chemokines?. J. Neuroimmunol. 2008, 198:46-55.
23. He J., Chen Y., Farzan M., Choe H., Ohagen A., Gartner S., Busciglio J., Yang X., Hofmann W., Newman W., Mackay C.R., Sodroski J., Gabuzda D. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 1997, 385:645-649.
24. Heaton R.K., Franklin D.R., Ellis R.J., McCutchan J.A., Letendre S.L., Leblanc S., Corkran S.H., Duarte N.A., Clifford D.B., Woods S.P., Collier A.C., Marra C.M., Morgello S., Mindt M.R., Taylor M.J., Marcotte T.D., Atkinson J.H., Wolfson T., Gelman B.B., McArthur J.C., Simpson D.M., Abramson I., Gamst A., Fennema-Notestine C., Jernigan T.L., Wong J., Grant I. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J. Neurovirol. 2011, 17:3-16.
25. Huang Z.B., Sheng G.Q. Interleukin-1beta with learning and memory. Neurosci. Bull. 2010, 26:455-468.
26. Huang Y.S., Hwang S.J., Chan C.Y., Wu J.C., Chao Y., Chang F.Y., Lee S.D. Serum levels of cytokines in hepatitis C-related liver disease: a longitudinal study. Zhonghua Yi Xue Za Zhi (Taipei) 1999, 62:327-333.
27. Huckans M., Seelye A., Parcel T., Mull L., Woodhouse J., Bjornson D., Fuller B.E., Loftis J.M., Morasco B.J., Sasaki A.W., Storzbach D., Hauser P. The cognitive effects of hepatitis C in the presence and absence of a history of substance use disorder. J. Int. Neuropsychol. Soc. 2009, 15:69-82.
28. Hung C.H., Lee C.M., Chen C.H., Hu T.H., Jiang S.R., Wang J.H., Lu S.N., Wang P.W. Association of inflammatory and anti-inflammatory cytokines with insulin resistance in chronic hepatitis C. Liver Int. 2009, 29:1086-1093.
29. Kaul M., Lipton S.A. Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:8212-8216.
30. Kim B.O., Liu Y., Zhou B.Y., He J.J. Induction of C chemokine XCL1 (lymphotactin/single C motif-1 alpha/activation-induced, T cell-derived and chemokine-related cytokine) expression by HIV-1 Tat protein. J. Immunol. 2004, 172:1888-1895.
31. Krebs F.C., Ross H., Mcallister J., Wigdahl B. HIV-1-associated central nervous system dysfunction. Adv. Pharmacol. 2000, 49:315-385.
32. Langford D., Masliah E. Crosstalk between components of the blood brain barrier and cells of the CNS in microglial activation in AIDS. Brain Pathol. 2001, 11:306-312.
33. Laurenzi M.A., Siden A., Persson M.A., Norkrans G., Hagberg L., Chiodi F. Cerebrospinal fluid interleukin-6 activity in HIV infection and inflammatory and noninflammatory diseases of the nervous system. Clin. Immunol. Immunopathol. 1990, 57:233-241.
34. Lemmers A., Gustot T., Durnez A., Evrard S., Moreno C., Quertinmont E., Vercruysse V., Demetter P., Franchimont D., Le Moine O., Geerts A., Deviere J. An inhibitor of interleukin-6 trans-signalling, sgp130, contributes to impaired acute phase response in human chronic liver disease. Clin. Exp. Immunol. 2009, 156:518-527.
35. Lewis S.D., Butchi N.B., Khaleduzzaman M., Morgan T.W., Du M., Pourciau S., Baker D.G., Akira S., Peterson K.E. Toll-like receptor 7 is not necessary for retroviral neuropathogenesis but does contribute to virus-induced neuroinflammation. J. Neurovirol. 2008, 1-11.
36. Lokensgard J.R., Gekker G., Ehrlich L.C., Hu S., Chao C.C., Peterson P.K. Proinflammatory cytokines inhibit HIV-1(SF162) expression in acutely infected human brain cell cultures. J. Immunol. 1997, 158:2449-2455.
37. Merrill J.E., Chen I.S. HIV-1, macrophages, glial cells, and cytokines in AIDS nervous system disease. FASEB J. 1991, 5:2391-2397.
38. Minagar A., Shapshak P., Fujimura R., Ownby R., Heyes M., Eisdorfer C. The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis. J. Neurol. Sci. 2002, 202:13-23.
39. Na H., Acharjee S., Jones G., Vivithanaporn P., Noorbakhsh F., McFarlane N., Maingat F., Ballanyi K., Pardo C.A., Cohen E.A., Power C. Interactions between human immunodeficiency virus (HIV)-1 Vpr expression and innate immunity influence neurovirulence. Retrovirology 2011, 8:44.
40. Nishitsuji H., Funami K., Shimizu Y., Ujino S., Sugiyama K., Seya T., Takaku H., Shimotohno K. Hepatitis C virus infection induces inflammatory cytokines and chemokines mediated by the cross talk between hepatocytes and stellate cells. J. Virol. 2013, 87:8169-8178.
41. Nukuna A., Gendelman H.E., Limoges J., Rasmussen J., Poluektova L., Ghorpade A., Persidsky Y. Levels of human immunodeficiency virus type 1 (HIV-1) replication in macrophages determines the severity of murine HIV-1 encephalitis. J. Neurovirol. 2004, 10(Suppl. 1):82-90.
42. Okamoto M., Wang X., Debyser Z., De Clercq E., Baba M. Establishment of an in vitro assay system mimicking human immunodeficiency virus type 1-induced neural cell death and evaluation of inhibitors thereof. J. Virol. Methods 2003, 108:195-203.
43. Paul R.H., Yiannoutsos C.T., Miller E.N., Chang L., Marra C.M., Schifitto G., Ernst T., Singer E., Richards T., Jarvik G.J., Price R., Meyerhoff D.J., Kolson D., Ellis R.J., Gonzalez G., Lenkinski R.E., Cohen R.A., Navia B.A. Proton MRS and neuropsychological correlates in AIDS dementia complex: evidence of subcortical specificity. J. Neuropsychiatry Clin. Neurosci. 2007, 19:283-292.
44. Paul R.H., Ernst T., Brickman A.M., Yiannoutsos C.T., Tate D.F., Cohen R.A., Navia B.A. Relative sensitivity of magnetic resonance spectroscopy and quantitative magnetic resonance imaging to cognitive function among nondemented individuals infected with HIV. J. Int. Neuropsychol. Soc. 2008, 14:725-733.
45. Persidsky Y., Buttini M., Limoges J., Bock P., Gendelman H.E. An analysis of HIV-1-associated inflammatory products in brain tissue of humans and SCID mice with HIV-1 encephalitis. J. Neurovirol. 1997, 3:401-416.
46. Poluektova L., Gorantla S., Faraci J., Birusingh K., Dou H., Gendelman H.E. Neuroregulatory events follow adaptive immune-mediated elimination of HIV-1-infected macrophages: studies in a murine model of viral encephalitis. J. Immunol. 2004, 172:7610-7617.
47. Potula R., Dhillion N., Sui Y., Zien C.A., Funa K., Pinson D., Mayo M.S., Singh D.K., Narayan O., Buch S. Association of platelet-derived growth factor-B chain with simian human immunodeficiency virus encephalitis. Am. J. Pathol. 2004, 165:815-824.
48. Robertson K.R., Su Z., Margolis D.M., Krambrink A., Havlir D.V., Evans S., Skiest D.J. Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort. Neurology 2010, 74:1260-1266.
49. Robinson-Papp J., Elliott K.J., Simpson D.M. HIV-related neurocognitive impairment in the HAART era. Curr. HIV/AIDS Rep. 2009, 6:146-152.
50. Rostasy K., Monti L., Yiannoutsos C., Wu J., Bell J., Hedreen J., Navia B.A. NFkappaB activation, TNF-alpha expression, and apoptosis in the AIDS-dementia-complex. J. Neurovirol. 2000, 6:537-543.
51. Sabri F., Titanji K., De Milito A., Chiodi F. Astrocyte activation and apoptosis: their roles in the neuropathology of HIV infection. Brain Pathol. 2003, 13:84-94.
52. Sas A.R., Bimonte-Nelson H., Smothers C.T., Woodward J., Tyor W.R. Interferon-alpha causes neuronal dysfunction in encephalitis. J. Neurosci. 2009, 29:3948-3955.
53. Sawada M., Imamura K., Nagatsu T. Role of cytokines in inflammatory process in Parkinson's disease. J. Neural Transm. Suppl. 2006, 373-381.
54. Schoeniger-Skinner D.K., Ledeboer A., Frank M.G., Milligan E.D., Poole S., Martin D., Maier S.F., Watkins L.R. Interleukin-6 mediates low-threshold mechanical allodynia induced by intrathecal HIV-1 envelope glycoprotein gp120. Brain Behav. Immun. 2007, 21:660-667.
55. Schouten J., Cinque P., Gisslen M., Reiss P., Portegies P. HIV-1 infection and cognitive impairment in the cART era: a review. AIDS 2011, 25:561-575.
56. Shah A., Kumar A. HIV-1 gp120-mediated increases in IL-8 production in astrocytes are mediated through the NF-kappaB pathway and can be silenced by gp120-specific siRNA. J. Neuroinflammation 2010, 7:96.
57. Shah A., Singh D.P., Buch S., Kumar A. HIV-1 envelope protein gp120 up regulates CCL5 production in astrocytes which can be circumvented by inhibitors of NF-kappaB pathway. Biochem. Biophys. Res. Commun. 2011, 414:112-117.
58. Shah A., Verma A.S., Patel K.H., Noel R., Rivera-Amill V., Silverstein P.S., Chaudhary S., Bhat H.K., Stamatatos L., Singh D.P., Buch S., Kumar A. HIV-1 gp120 induces expression of IL-6 through a nuclear factor-kappa B-dependent mechanism: suppression by gp120 specific small interfering RNA. PLoS One 2011, 6:e21261.
59. Si Q., Cosenza M., Zhao M.L., Goldstein H., Lee S.C. GM-CSF and M-CSF modulate beta-chemokine and HIV-1 expression in microglia. Glia 2002, 39:174-183.
60. Silverstein P.S., Shah A., Weemhoff J., Kumar S., Singh D.P., Kumar A. HIV-1 gp120 and drugs of abuse: interactions in the central nervous system. Curr. HIV Res. 2012, 10:369-383.
61. Sui Y., Potula R., Pinson D., Adany I., Li Z., Day J., Buch E., Segebrecht J., Villinger F., Liu Z., Huang M., Narayan O., Buch S. Microarray analysis of cytokine and chemokine genes in the brains of macaques with SHIV-encephalitis. J. Med. Primatol. 2003, 32:229-239.
62. Thompson K.A., Mcarthur J.C., Wesselingh S.L. Correlation between neurological progression and astrocyte apoptosis in HIV-associated dementia. Ann. Neurol. 2001, 49:745-752.
63. Woods S.P., Scott J.C., Dawson M.S., Morgan E.E., Carey C.L., Heaton R.K., Grant I. Construct validity of Hopkins Verbal Learning Test-Revised component process measures in an HIV-1 sample. Arch. Clin. Neuropsychol. 2005, 20:1061-1071.
64. Woods S.P., Morgan E.E., Marquie-Beck J., Carey C.L., Grant I., Letendre S.L. Markers of macrophage activation and axonal injury are associated with prospective memory in HIV-1 disease. Cogn. Behav. Neurol. 2006, 19:217-221.
65. Woods S.P., Moore D.J., Weber E., Grant I. Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol. Rev. 2009, 19:152-168.
66. Yeni P. Update on HAART in HIV. J. Hepatol. 2006, 44:S100-S103.
67. Zhang L., Miao L., Han F., Dou X.G. Cytokine levels in serum of patients with chronic hepatitis C and its significance. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2011, 27:301-303.